Merck Animal Health Completes Acquisition of Vaki to Further Broaden Its Leadership Position in Aquaculture to Advance Fish Health and Welfare
Dateline City:
MADISON, N.J.
Strategic Transaction Benefits and Improves Aquaculture Health and Performance
MADISON, N.J.–(BUSINESS WIRE)–Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of Vaki, a leader in fish farming and wild fish conservation monitoring equipment and real-time video monitoring technology to advance fish health and welfare, from Pentair (NYSE:PNR), a leading global water treatment company.
Language:
English
Contact:
Merck Media:
Noreen Verbrugge
+ 1 (973) 937-5450
[email protected]
Pam Eisele
+1 (267) 305-3558
[email protected]
Merck Investors:
Michael DeCarbo
+ 1 (908) 740-1807
[email protected]
Pentair Media:
Rebecca Osborn
+ 1 (763) 656-5589
[email protected]
Ticker Slug:
Ticker:
MRK
Exchange:
NYSE
Ticker:
PNR
Exchange:
NYSE
@MerckAH
